Olink Proteomics

📍 Uppsala, Sweden🗓 Founded 2004👥 582 employees💰 Last funded Jun 2019
Biotechnology Research🌐 olink.com
Website LinkedIn
Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways. Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base. For more information visit www.olink.com
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
2004
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Sweden
1
Frequently asked questions
Who invested in Olink Proteomics?
Olink Proteomics has 2 investors on record on gritt.io.
When did Olink Proteomics last raise funding?
The most recent investment in Olink Proteomics recorded on gritt.io was in June 2019.
When was Olink Proteomics founded?
Olink Proteomics was founded in 2004.
What industry is Olink Proteomics in?
Olink Proteomics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Olink Proteomics based?
Olink Proteomics is headquartered in Uppsala, Sweden.